{"id":1182,"date":"2025-12-05T14:32:00","date_gmt":"2025-12-05T14:32:00","guid":{"rendered":"https:\/\/retina-eye.co.uk\/?p=1182"},"modified":"2026-06-03T12:18:45","modified_gmt":"2026-06-03T12:18:45","slug":"who-are-more-likely-to-develop-central-serous-chorioretinopathy-cscr","status":"publish","type":"post","link":"https:\/\/www.retina-eye.co.uk\/zh\/post\/who-are-more-likely-to-develop-central-serous-chorioretinopathy-cscr\/","title":{"rendered":"\u54ea\u4e9b\u4eba\u7fa4\u66f4\u5bb9\u6613\u60a3\u4e0a\u4e2d\u592e\u6d46\u6db2\u6027\u8109\u7edc\u819c\u89c6\u7f51\u819c\u75c5\u53d8\uff08CSCR\uff09\uff1f"},"content":{"rendered":"\n<h2 class=\"wp-block-heading\" id=\"viewer-tlxxg39756\">Key Takeaways<\/h2>\n\n\n\n<ul class=\"wp-block-list\">\n<li>CSCR tends to affect younger to middle-aged adults, especially men. It is most commonly seen in males aged roughly 30\u201350 years.<\/li>\n\n\n\n<li>Stress, corticosteroid use, and systemic conditions are major contributors. Elevated cortisol levels, steroid medications, hypertension, and sleep apnea significantly increase susceptibility.<\/li>\n\n\n\n<li>This disease has been found to have higher prevalence in men than women. Several population studies report a male-to-female ratio of roughly 6:1.<\/li>\n\n\n\n<li>Understanding risk factors encourages early monitoring and timely care. Individuals who fall into multiple risk categories should promptly seek evaluation if they experience blurred or distorted central vision.<\/li>\n<\/ul>\n\n\n\n<p class=\"wp-block-paragraph\" id=\"viewer-qp2sg37428\">Central Serous Chorioretinopathy (CSCR) is a retinal disorder involving fluid accumulation beneath the macula, the central area of the retina responsible for sharp, detailed vision [1]. This fluid collects due to leakage from the retinal pigment epithelium (RPE), causing the macula to elevate slightly.&nbsp;<\/p>\n\n\n\n<p class=\"wp-block-paragraph\" id=\"viewer-7sv5n34448\">As a result, patients may experience visual distortion, blurriness, or a darkened central spot. While symptoms sometimes resolve naturally, certain patients are more likely to develop CSCR and more prone to recurrences, making early evaluation and appropriate central serous chorioretinopathy treatment essential [2].<\/p>\n\n\n\n<h2 class=\"wp-block-heading\" id=\"viewer-42pmi34450\">Understanding the Basics of CSCR<\/h2>\n\n\n\n<p class=\"wp-block-paragraph\" id=\"viewer-m5t1w34452\">CSCR is often associated with stress and systemic factors that elevate cortisol levels. The condition causes a localized detachment of the neurosensory retina when fluid accumulates under the macula.&nbsp;<\/p>\n\n\n\n<p class=\"wp-block-paragraph\" id=\"viewer-61mrn34454\">In many cases, symptoms improve spontaneously within weeks or months. However, persistent or recurrent CSCR can damage the retina over time and may require <a target=\"_blank\" href=\"https:\/\/www.retina-eye.co.uk\/post\/lifestyle-changes-post-treatment-a-guide-for-private-central-serous-retinopathy-patients\" rel=\"noreferrer noopener\"><u>central serous chorioretinopathy treatment<\/u><\/a>&nbsp;to prevent sustained vision impairment.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\" id=\"viewer-g7xca34458\">Although commonly diagnosed in younger adults, CSCR can also affect older individuals and women. The condition usually presents without pain, but the visual disturbances can significantly impact reading, driving, and tasks that require central vision.<\/p>\n\n\n\n<h2 class=\"wp-block-heading\" id=\"viewer-pljpa34460\">Higher Risk in Men Between Ages 20 to 50<\/h2>\n\n\n\n<p class=\"wp-block-paragraph\" id=\"viewer-t2ugv34462\">One of the strongest risk factors for CSCR is gender, with men aged 30 to 50 disproportionately affected [3]. Hormonal differences, particularly those related to cortisol regulation, may contribute to this disparity. Occupational stressors, competitive environments, and physically demanding work may place men in this age group at increased risk.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\" id=\"viewer-0kpqk34464\">While CSCR can occur in women, the difference in risk remains notable across multiple studies. This demographic pattern highlights the importance of routine eye examinations for men experiencing visual symptoms, especially those with chronic stress or high-pressure lifestyles.<\/p>\n\n\n\n<h2 class=\"wp-block-heading\" id=\"viewer-lsmx034466\">Individuals with High Stress or Anxiety Levels<\/h2>\n\n\n\n<p class=\"wp-block-paragraph\" id=\"viewer-om9pv34468\">Chronic stress is one of the most significant contributors to CSCR because elevated cortisol can affect both the retinal pigment epithelium and the choroidal blood vessels beneath the retina [4]. When cortisol remains consistently high, fluid regulation in the eye becomes disrupted, making leakage more likely.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\" id=\"viewer-621lf34470\">People working long hours, managing demanding careers, or facing significant emotional strain may face heightened risk. Stress does not need to be work-related to have an impact; relationship conflicts, financial difficulties, and ongoing anxiety can also contribute.&nbsp;<\/p>\n\n\n\n<p class=\"wp-block-paragraph\" id=\"viewer-4o9hv34472\">Managing stress through counseling, meditation, breathing exercises, or physical activity may help reduce the likelihood of recurrence and improve response to <a target=\"_blank\" href=\"https:\/\/www.retina-eye.co.uk\/central-serous-chorioretinopathy-treatment\" rel=\"noreferrer noopener\"><u>central serous chorioretinopathy treatment<\/u><\/a>.<\/p>\n\n\n\n<h2 class=\"wp-block-heading\" id=\"viewer-zhkh634476\">Users of Corticosteroid Medications<\/h2>\n\n\n\n<p class=\"wp-block-paragraph\" id=\"viewer-0wbtm34478\">Corticosteroids are widely used to manage inflammatory, respiratory, allergic, and autoimmune conditions. Unfortunately, prolonged or high-dose steroid use\u2014regardless of the route\u2014raises the risk of CSCR. This includes:<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li>Oral corticosteroids<\/li>\n\n\n\n<li>Inhaled steroids for asthma<\/li>\n\n\n\n<li>Nasal sprays for allergies<\/li>\n\n\n\n<li>Topical creams or ointments<\/li>\n\n\n\n<li>Steroid injections<\/li>\n<\/ul>\n\n\n\n<p class=\"wp-block-paragraph\" id=\"viewer-oybjs36330\">Even frequent use of over-the-counter topical steroids may increase risk. For individuals who develop CSCR while taking steroids, healthcare providers may recommend adjusting or discontinuing the medication in addition to considering <a target=\"_blank\" href=\"https:\/\/www.retina-eye.co.uk\/post\/lifestyle-changes-post-treatment-a-guide-for-private-central-serous-retinopathy-patients\" rel=\"noreferrer noopener\"><u>central serous chorioretinopathy treatment<\/u><\/a>.<\/p>\n\n\n\n<h2 class=\"wp-block-heading\" id=\"viewer-u33mc34500\">Individuals with Type A Personality Traits<\/h2>\n\n\n\n<p class=\"wp-block-paragraph\" id=\"viewer-gs4ps34502\">People with Type A personality characteristics often experience elevated cortisol and adrenaline levels due to competitive tendencies, perfectionism, and fast-paced routines [5]. These individuals may unintentionally overlook early symptoms or postpone eye assessments, increasing the risk of prolonged fluid accumulation in the retina. Awareness and timely eye care are particularly important for those with Type A tendencies, especially when combined with other risk factors such as stress or steroid use.<\/p>\n\n\n\n<h2 class=\"wp-block-heading\" id=\"viewer-kxw0j34504\">People with Hypertension or Cardiovascular Issues<\/h2>\n\n\n\n<p class=\"wp-block-paragraph\" id=\"viewer-bhrlp34506\">Systemic health conditions significantly influence CSCR risk. Hypertension, sleep apnea, and metabolic or cardiovascular disorders may affect choroidal blood flow, increasing pressure within the layers beneath the retina. This heightened pressure can make fluid leakage more likely.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\" id=\"viewer-kogy434508\">Managing blood pressure, improving sleep quality, and addressing underlying cardiovascular issues can help lower the chances of recurrence and support the effectiveness of <a target=\"_blank\" href=\"https:\/\/www.retina-eye.co.uk\/central-serous-chorioretinopathy-treatment\" rel=\"noreferrer noopener\"><u>central serous chorioretinopathy treatment<\/u><\/a>.<\/p>\n\n\n\n<h2 class=\"wp-block-heading\" id=\"viewer-dl43e34512\">Pregnant Women and Hormonal Influences<\/h2>\n\n\n\n<p class=\"wp-block-paragraph\" id=\"viewer-qypxe34514\">Although CSCR is rare in pregnancy, hormonal fluctuations and naturally elevated cortisol levels can make pregnant women more susceptible. In many cases, CSCR that develops during pregnancy resolves after delivery. Nevertheless, regular monitoring ensures that visual function remains stable and that the condition does not progress.<\/p>\n\n\n\n<h2 class=\"wp-block-heading\" id=\"viewer-ggdpe34516\">Frequent Use of Stimulants<\/h2>\n\n\n\n<p class=\"wp-block-paragraph\" id=\"viewer-4k96s34518\">Caffeine, nicotine, and energy drinks increase cortisol and adrenaline, which may influence the choroidal circulation. While occasional stimulant use is usually safe, frequent or excessive intake may heighten risk, particularly when combined with stress or other contributing factors. Smoking and vaping have additional negative effects on retinal and vascular health.<\/p>\n\n\n\n<h2 class=\"wp-block-heading\" id=\"viewer-ii3vd34520\">Individuals with Previous CSCR Episodes<\/h2>\n\n\n\n<p class=\"wp-block-paragraph\" id=\"viewer-9344g34522\">Patients who have experienced CSCR once are at higher risk of recurrence, highlighting the need for close monitoring and timely treatment [6]. Identifying symptom patterns early\u2014such as sudden blurring or central visual distortion\u2014allows for prompt evaluation and <a target=\"_blank\" href=\"https:\/\/www.retina-eye.co.uk\/post\/central-serous-chorioretinopathy-cscr-when-should-i-seek-treatment\" rel=\"noreferrer noopener\"><u>timely CSCR treatment<\/u><\/a>&nbsp;before damage becomes permanent.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\" id=\"viewer-m2ypr34526\">The following table summarizes the key groups and risk factors associated with a higher likelihood of developing CSCR.<\/p>\n\n\n\n<figure class=\"wp-block-table\"><table class=\"has-fixed-layout\"><tbody><tr><td><strong>Risk Factor \/ Group<\/strong><\/td><td><strong>Description \/ Notes<\/strong><\/td><\/tr><tr><td><strong>Men aged 30\u201350<\/strong><\/td><td>Hormonal differences and lifestyle factors contribute to higher susceptibility.<\/td><\/tr><tr><td><strong>High stress or anxiety<\/strong><\/td><td>Elevated cortisol disrupts retinal fluid regulation; includes occupational, emotional, or relationship stress.<\/td><\/tr><tr><td><strong>Corticosteroid users<\/strong><\/td><td>Oral, inhaled, topical, or injected steroids increase risk; even frequent OTC steroid use may contribute.<\/td><\/tr><tr><td><strong>Type A personality<\/strong><\/td><td>Competitive, perfectionist tendencies elevate cortisol and may delay symptom recognition.<\/td><\/tr><tr><td><strong>Hypertension \/ cardiovascular issues<\/strong><\/td><td>Systemic conditions affect choroidal blood flow, increasing fluid leakage risk.<\/td><\/tr><tr><td><strong>Pregnancy<\/strong><\/td><td>Hormonal fluctuations and higher cortisol levels may predispose to CSCR; usually resolves postpartum.<\/td><\/tr><tr><td><strong>Frequent stimulant use<\/strong><\/td><td>Caffeine, nicotine, and energy drinks may increase cortisol and choroidal stress.<\/td><\/tr><tr><td><strong>Previous CSCR episodes<\/strong><\/td><td>History of CSCR increases likelihood of recurrence; early monitoring is essential.<\/td><\/tr><\/tbody><\/table><\/figure>\n\n\n\n<h2 class=\"wp-block-heading\" id=\"viewer-gqccu34592\">When Treatment Becomes Necessary<\/h2>\n\n\n\n<p class=\"wp-block-paragraph\" id=\"viewer-47zyi34594\">Although many cases resolve spontaneously, persistent, recurrent, or severe CSCR may require intervention. <a target=\"_blank\" href=\"https:\/\/www.retina-eye.co.uk\/post\/real-life-cases-of-cscr-treatment\" rel=\"noreferrer noopener\"><u>Common central serous chorioretinopathy care<\/u><\/a>&nbsp;options include:<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li><strong>Photodynamic therapy<\/strong>, which targets abnormal choroidal circulation<\/li>\n\n\n\n<li><strong>Thermal laser therapy<\/strong>\u00a0for specific leakage points<\/li>\n\n\n\n<li><strong>Medications<\/strong>\u00a0that reduce choroidal vascular permeability or modulate cortisol pathways<\/li>\n<\/ul>\n\n\n\n<p class=\"wp-block-paragraph\" id=\"viewer-varxi35138\">Ophthalmologists may also advise lifestyle adjustments to improve outcomes, such as reducing stress, avoiding unnecessary steroid use, and managing systemic health conditions.<\/p>\n\n\n\n<h2 class=\"wp-block-heading\" id=\"viewer-mzuam34613\">Taking Proactive Steps to Protect Vision<\/h2>\n\n\n\n<p class=\"wp-block-paragraph\" id=\"viewer-a6pu134615\">Awareness of risk factors enables individuals to take early steps to safeguard their vision. Anyone who falls into a higher-risk group should monitor for symptoms such as blurry central vision, distortion of straight lines, or difficulty focusing.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\" id=\"viewer-ipk0d34617\">Prompt evaluation leads to earlier intervention, whether observation or <a target=\"_blank\" href=\"https:\/\/www.retina-eye.co.uk\/post\/risks-and-side-effects-of-central-serous-chorioretinopathy-treatment\" rel=\"noreferrer noopener\"><u>central serous chorioretinopathy management<\/u><\/a>&nbsp;is needed. Although CSCR typically does not cause permanent vision loss when detected early, repeated episodes can damage the retina over time. Understanding personal risk empowers individuals to protect their eyesight, maintain ocular health, and reduce the likelihood of long-term complications.<\/p>\n\n\n\n<h2 class=\"wp-block-heading\" id=\"viewer-1fiar34621\">References<\/h2>\n\n\n\n<ol class=\"wp-block-list\">\n<li>National Eye Institute. (2023). Central serous chorioretinopathy. U.S. Department of Health and Human Services.<a href=\"https:\/\/www.nei.nih.gov\/learn-about-eye-health\/eye-conditions-and-diseases\/central-serous-chorioretinopathy\" target=\"_blank\" rel=\"noreferrer noopener\"><u>\u00a0<\/u><\/a><a href=\"https:\/\/www.nei.nih.gov\/learn-about-eye-health\/eye-conditions-and-diseases\/central-serous-chorioretinopathy\" target=\"_blank\" rel=\"noreferrer noopener\"><u>https:\/\/www.nei.nih.gov\/learn-about-eye-health\/eye-conditions-and-diseases\/central-serous-chorioretinopathy<\/u><\/a><\/li>\n\n\n\n<li>Liew, G., Quin, G., Gillies, M., &amp; Fraser-Bell, S. (2013). Central serous chorioretinopathy: A review of epidemiology and pathophysiology. Clinical &amp; Experimental Ophthalmology, 41(2), 201\u2013214.<a href=\"https:\/\/doi.org\/10.1111\/ceo.12033\" target=\"_blank\" rel=\"noreferrer noopener\"><u>\u00a0<\/u><\/a><a href=\"https:\/\/doi.org\/10.1111\/ceo.12033\" target=\"_blank\" rel=\"noreferrer noopener\"><u>https:\/\/doi.org\/10.1111\/ceo.12033<\/u><\/a><\/li>\n\n\n\n<li>van Dijk, E. H., Fauser, S., Breukink, M. B., Blanco-Garavito, R., van Rijssen, T. J., &amp; Keunen, J. E. E. (2019). Risk factors and clinical presentation of central serous chorioretinopathy in men. Ophthalmology Retina, 3(6), 504\u2013512.<a href=\"https:\/\/doi.org\/10.1016\/j.oret.2019.01.008\" target=\"_blank\" rel=\"noreferrer noopener\"><u>\u00a0<\/u><\/a><a href=\"https:\/\/doi.org\/10.1016\/j.oret.2019.01.008\" target=\"_blank\" rel=\"noreferrer noopener\"><u>https:\/\/doi.org\/10.1016\/j.oret.2019.01.008<\/u><\/a><\/li>\n\n\n\n<li>Wang, M., Munch, I. C., Hasler, P. W., Pr\u00fcnte, C., Larsen, M. (2008). Central serous chorioretinopathy. Acta Ophthalmologica, 86(2), 126\u2013145.<a href=\"https:\/\/doi.org\/10.1111\/j.1600-0420.2007.00970.x\" target=\"_blank\" rel=\"noreferrer noopener\"><u>\u00a0<\/u><\/a><a href=\"https:\/\/doi.org\/10.1111\/j.1600-0420.2007.00970.x\" target=\"_blank\" rel=\"noreferrer noopener\"><u>https:\/\/doi.org\/10.1111\/j.1600-0420.2007.00970.x<\/u><\/a><\/li>\n\n\n\n<li>Chrapek, M., K\u0142os, P., &amp; Stankiewicz, A. (2020). Psychosocial factors in central serous chorioretinopathy. Medical Hypothesis, Discovery &amp; Innovation Ophthalmology Journal, 9(1), 26\u201331.<a href=\"https:\/\/www.ncbi.nlm.nih.gov\/pmc\/articles\/PMC7002393\/\" target=\"_blank\" rel=\"noreferrer noopener\"><u>\u00a0<\/u><\/a><a href=\"https:\/\/www.ncbi.nlm.nih.gov\/pmc\/articles\/PMC7002393\/\" target=\"_blank\" rel=\"noreferrer noopener\"><u>https:\/\/www.ncbi.nlm.nih.gov\/pmc\/articles\/PMC7002393\/<\/u><\/a><\/li>\n\n\n\n<li>Daruich, A., Matet, A., Behar-Cohen, F. (2015). Central serous chorioretinopathy: Recurrence and chronicity. International Ophthalmology, 35(6), 871\u2013888.<a href=\"https:\/\/doi.org\/10.1007\/s10792-015-0037-4\" target=\"_blank\" rel=\"noreferrer noopener\"><u>\u00a0<\/u><\/a><\/li>\n<\/ol>\n","protected":false},"excerpt":{"rendered":"<p>Key Takeaways Central Serous Chorioretinopathy (CSCR) is a retinal disorder involving fluid accumulation beneath the macula, the central area of the retina responsible for sharp, detailed vision [1]. This fluid collects due to leakage from the retinal pigment epithelium (RPE), causing the macula to elevate slightly.&nbsp; As a result, patients may experience visual distortion, blurriness, [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":2314,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[1],"tags":[],"class_list":["post-1182","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-uncategorized"],"acf":[],"aioseo_notices":[],"aioseo_head":"\n\t\t<!-- All in One SEO 4.9.10 - aioseo.com -->\n\t<meta name=\"description\" content=\"CSCR mainly affects men aged 30\u201350. Stress, steroid use, hypertension, and Type A traits increase risk. Early detection helps protect central vision.\" \/>\n\t<meta name=\"robots\" content=\"max-image-preview:large\" \/>\n\t<meta name=\"author\" content=\"admin\"\/>\n\t<link rel=\"canonical\" href=\"https:\/\/www.retina-eye.co.uk\/zh\/post\/who-are-more-likely-to-develop-central-serous-chorioretinopathy-cscr\/\" \/>\n\t<meta name=\"generator\" content=\"All in One SEO (AIOSEO) 4.9.10\" \/>\n\t\t<meta property=\"og:locale\" content=\"zh_CN\" \/>\n\t\t<meta property=\"og:site_name\" content=\"Retina Eye - Ms Sharon (Ling Zhi) Heng MBBS, PhD, FRCOphth, FHEA Consultant Ophthalmic Surgeon\" \/>\n\t\t<meta property=\"og:type\" content=\"article\" \/>\n\t\t<meta property=\"og:title\" content=\"Who Is at Higher Risk for Central Serous Chorioretinopathy\" \/>\n\t\t<meta property=\"og:description\" content=\"CSCR mainly affects men aged 30\u201350. Stress, steroid use, hypertension, and Type A traits increase risk. Early detection helps protect central vision.\" \/>\n\t\t<meta property=\"og:url\" content=\"https:\/\/www.retina-eye.co.uk\/zh\/post\/who-are-more-likely-to-develop-central-serous-chorioretinopathy-cscr\/\" \/>\n\t\t<meta property=\"og:image\" content=\"https:\/\/retina-eye.co.uk\/wp-content\/uploads\/2026\/03\/retina-eye-logo.png\" \/>\n\t\t<meta property=\"og:image:secure_url\" content=\"https:\/\/retina-eye.co.uk\/wp-content\/uploads\/2026\/03\/retina-eye-logo.png\" \/>\n\t\t<meta property=\"article:published_time\" content=\"2025-12-05T14:32:00+00:00\" \/>\n\t\t<meta property=\"article:modified_time\" content=\"2026-06-03T12:18:45+00:00\" \/>\n\t\t<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n\t\t<meta name=\"twitter:title\" content=\"Who Is at Higher Risk for Central Serous Chorioretinopathy\" \/>\n\t\t<meta name=\"twitter:description\" content=\"CSCR mainly affects men aged 30\u201350. Stress, steroid use, hypertension, and Type A traits increase risk. Early detection helps protect central vision.\" \/>\n\t\t<meta name=\"twitter:image\" content=\"https:\/\/retina-eye.co.uk\/wp-content\/uploads\/2026\/03\/retina-eye-logo.png\" \/>\n\t\t<script type=\"application\/ld+json\" class=\"aioseo-schema\">\n\t\t\t{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"BlogPosting\",\"@id\":\"https:\\\/\\\/www.retina-eye.co.uk\\\/zh\\\/post\\\/who-are-more-likely-to-develop-central-serous-chorioretinopathy-cscr\\\/#blogposting\",\"name\":\"Who Is at Higher Risk for Central Serous Chorioretinopathy\",\"headline\":\"Who Are More Likely to Develop Central Serous Chorioretinopathy (CSCR)?\",\"author\":{\"@id\":\"https:\\\/\\\/www.retina-eye.co.uk\\\/zh\\\/post\\\/author\\\/retinaeye\\\/#author\"},\"publisher\":{\"@id\":\"https:\\\/\\\/www.retina-eye.co.uk\\\/zh\\\/#organization\"},\"image\":{\"@type\":\"ImageObject\",\"url\":\"https:\\\/\\\/www.retina-eye.co.uk\\\/wp-content\\\/uploads\\\/2025\\\/12\\\/Who-Are-More-Likely-to-Develop-Central-Serous-Chorioretinopathy-CSCR.jpg\",\"width\":1000,\"height\":667},\"datePublished\":\"2025-12-05T14:32:00+00:00\",\"dateModified\":\"2026-06-03T12:18:45+00:00\",\"inLanguage\":\"zh-CN\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.retina-eye.co.uk\\\/zh\\\/post\\\/who-are-more-likely-to-develop-central-serous-chorioretinopathy-cscr\\\/#webpage\"},\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.retina-eye.co.uk\\\/zh\\\/post\\\/who-are-more-likely-to-develop-central-serous-chorioretinopathy-cscr\\\/#webpage\"},\"articleSection\":\"Uncategorized\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.retina-eye.co.uk\\\/zh\\\/post\\\/who-are-more-likely-to-develop-central-serous-chorioretinopathy-cscr\\\/#breadcrumblist\",\"itemListElement\":[{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/www.retina-eye.co.uk\\\/zh#listItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.retina-eye.co.uk\\\/zh\",\"nextItem\":{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/www.retina-eye.co.uk\\\/zh\\\/post\\\/category\\\/uncategorized\\\/#listItem\",\"name\":\"Uncategorized\"}},{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/www.retina-eye.co.uk\\\/zh\\\/post\\\/category\\\/uncategorized\\\/#listItem\",\"position\":2,\"name\":\"Uncategorized\",\"item\":\"https:\\\/\\\/www.retina-eye.co.uk\\\/zh\\\/post\\\/category\\\/uncategorized\\\/\",\"nextItem\":{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/www.retina-eye.co.uk\\\/zh\\\/post\\\/who-are-more-likely-to-develop-central-serous-chorioretinopathy-cscr\\\/#listItem\",\"name\":\"Who Are More Likely to Develop Central Serous Chorioretinopathy (CSCR)?\"},\"previousItem\":{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/www.retina-eye.co.uk\\\/zh#listItem\",\"name\":\"Home\"}},{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/www.retina-eye.co.uk\\\/zh\\\/post\\\/who-are-more-likely-to-develop-central-serous-chorioretinopathy-cscr\\\/#listItem\",\"position\":3,\"name\":\"Who Are More Likely to Develop Central Serous Chorioretinopathy (CSCR)?\",\"previousItem\":{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/www.retina-eye.co.uk\\\/zh\\\/post\\\/category\\\/uncategorized\\\/#listItem\",\"name\":\"Uncategorized\"}}]},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/www.retina-eye.co.uk\\\/zh\\\/#organization\",\"name\":\"Retina Eye\",\"description\":\"Ms Sharon (Ling Zhi) Heng MBBS, PhD, FRCOphth, FHEA Consultant Ophthalmic Surgeon\",\"url\":\"https:\\\/\\\/www.retina-eye.co.uk\\\/zh\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"url\":\"https:\\\/\\\/www.retina-eye.co.uk\\\/wp-content\\\/uploads\\\/2026\\\/07\\\/Retina-Eye-Uk-Logo-final.png\",\"@id\":\"https:\\\/\\\/www.retina-eye.co.uk\\\/zh\\\/post\\\/who-are-more-likely-to-develop-central-serous-chorioretinopathy-cscr\\\/#organizationLogo\",\"width\":498,\"height\":355},\"image\":{\"@id\":\"https:\\\/\\\/www.retina-eye.co.uk\\\/zh\\\/post\\\/who-are-more-likely-to-develop-central-serous-chorioretinopathy-cscr\\\/#organizationLogo\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.retina-eye.co.uk\\\/zh\\\/post\\\/author\\\/retinaeye\\\/#author\",\"url\":\"https:\\\/\\\/www.retina-eye.co.uk\\\/zh\\\/post\\\/author\\\/retinaeye\\\/\",\"name\":\"admin\",\"image\":{\"@type\":\"ImageObject\",\"@id\":\"https:\\\/\\\/www.retina-eye.co.uk\\\/zh\\\/post\\\/who-are-more-likely-to-develop-central-serous-chorioretinopathy-cscr\\\/#authorImage\",\"url\":\"https:\\\/\\\/www.retina-eye.co.uk\\\/wp-content\\\/litespeed\\\/avatar\\\/4670ef77034ec9acb289c5943cd6a2f6.jpg?ver=1785601329\",\"width\":96,\"height\":96,\"caption\":\"admin\"}},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.retina-eye.co.uk\\\/zh\\\/post\\\/who-are-more-likely-to-develop-central-serous-chorioretinopathy-cscr\\\/#webpage\",\"url\":\"https:\\\/\\\/www.retina-eye.co.uk\\\/zh\\\/post\\\/who-are-more-likely-to-develop-central-serous-chorioretinopathy-cscr\\\/\",\"name\":\"Who Is at Higher Risk for Central Serous Chorioretinopathy\",\"description\":\"CSCR mainly affects men aged 30\\u201350. Stress, steroid use, hypertension, and Type A traits increase risk. Early detection helps protect central vision.\",\"inLanguage\":\"zh-CN\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.retina-eye.co.uk\\\/zh\\\/#website\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.retina-eye.co.uk\\\/zh\\\/post\\\/who-are-more-likely-to-develop-central-serous-chorioretinopathy-cscr\\\/#breadcrumblist\"},\"author\":{\"@id\":\"https:\\\/\\\/www.retina-eye.co.uk\\\/zh\\\/post\\\/author\\\/retinaeye\\\/#author\"},\"creator\":{\"@id\":\"https:\\\/\\\/www.retina-eye.co.uk\\\/zh\\\/post\\\/author\\\/retinaeye\\\/#author\"},\"image\":{\"@type\":\"ImageObject\",\"url\":\"https:\\\/\\\/www.retina-eye.co.uk\\\/wp-content\\\/uploads\\\/2025\\\/12\\\/Who-Are-More-Likely-to-Develop-Central-Serous-Chorioretinopathy-CSCR.jpg\",\"@id\":\"https:\\\/\\\/www.retina-eye.co.uk\\\/zh\\\/post\\\/who-are-more-likely-to-develop-central-serous-chorioretinopathy-cscr\\\/#mainImage\",\"width\":1000,\"height\":667},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.retina-eye.co.uk\\\/zh\\\/post\\\/who-are-more-likely-to-develop-central-serous-chorioretinopathy-cscr\\\/#mainImage\"},\"datePublished\":\"2025-12-05T14:32:00+00:00\",\"dateModified\":\"2026-06-03T12:18:45+00:00\"},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.retina-eye.co.uk\\\/zh\\\/#website\",\"url\":\"https:\\\/\\\/www.retina-eye.co.uk\\\/zh\\\/\",\"name\":\"Retina Eye\",\"description\":\"Ms Sharon (Ling Zhi) Heng MBBS, PhD, FRCOphth, FHEA Consultant Ophthalmic Surgeon\",\"inLanguage\":\"zh-CN\",\"publisher\":{\"@id\":\"https:\\\/\\\/www.retina-eye.co.uk\\\/zh\\\/#organization\"}}]}\n\t\t<\/script>\n\t\t<!-- All in One SEO -->\n\n","aioseo_head_json":{"title":"Who Is at Higher Risk for Central Serous Chorioretinopathy","description":"CSCR mainly affects men aged 30\u201350. Stress, steroid use, hypertension, and Type A traits increase risk. Early detection helps protect central vision.","canonical_url":"https:\/\/www.retina-eye.co.uk\/zh\/post\/who-are-more-likely-to-develop-central-serous-chorioretinopathy-cscr\/","robots":"max-image-preview:large","keywords":"","webmasterTools":{"miscellaneous":""},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"BlogPosting","@id":"https:\/\/www.retina-eye.co.uk\/zh\/post\/who-are-more-likely-to-develop-central-serous-chorioretinopathy-cscr\/#blogposting","name":"Who Is at Higher Risk for Central Serous Chorioretinopathy","headline":"Who Are More Likely to Develop Central Serous Chorioretinopathy (CSCR)?","author":{"@id":"https:\/\/www.retina-eye.co.uk\/zh\/post\/author\/retinaeye\/#author"},"publisher":{"@id":"https:\/\/www.retina-eye.co.uk\/zh\/#organization"},"image":{"@type":"ImageObject","url":"https:\/\/www.retina-eye.co.uk\/wp-content\/uploads\/2025\/12\/Who-Are-More-Likely-to-Develop-Central-Serous-Chorioretinopathy-CSCR.jpg","width":1000,"height":667},"datePublished":"2025-12-05T14:32:00+00:00","dateModified":"2026-06-03T12:18:45+00:00","inLanguage":"zh-CN","mainEntityOfPage":{"@id":"https:\/\/www.retina-eye.co.uk\/zh\/post\/who-are-more-likely-to-develop-central-serous-chorioretinopathy-cscr\/#webpage"},"isPartOf":{"@id":"https:\/\/www.retina-eye.co.uk\/zh\/post\/who-are-more-likely-to-develop-central-serous-chorioretinopathy-cscr\/#webpage"},"articleSection":"Uncategorized"},{"@type":"BreadcrumbList","@id":"https:\/\/www.retina-eye.co.uk\/zh\/post\/who-are-more-likely-to-develop-central-serous-chorioretinopathy-cscr\/#breadcrumblist","itemListElement":[{"@type":"ListItem","@id":"https:\/\/www.retina-eye.co.uk\/zh#listItem","position":1,"name":"Home","item":"https:\/\/www.retina-eye.co.uk\/zh","nextItem":{"@type":"ListItem","@id":"https:\/\/www.retina-eye.co.uk\/zh\/post\/category\/uncategorized\/#listItem","name":"Uncategorized"}},{"@type":"ListItem","@id":"https:\/\/www.retina-eye.co.uk\/zh\/post\/category\/uncategorized\/#listItem","position":2,"name":"Uncategorized","item":"https:\/\/www.retina-eye.co.uk\/zh\/post\/category\/uncategorized\/","nextItem":{"@type":"ListItem","@id":"https:\/\/www.retina-eye.co.uk\/zh\/post\/who-are-more-likely-to-develop-central-serous-chorioretinopathy-cscr\/#listItem","name":"Who Are More Likely to Develop Central Serous Chorioretinopathy (CSCR)?"},"previousItem":{"@type":"ListItem","@id":"https:\/\/www.retina-eye.co.uk\/zh#listItem","name":"Home"}},{"@type":"ListItem","@id":"https:\/\/www.retina-eye.co.uk\/zh\/post\/who-are-more-likely-to-develop-central-serous-chorioretinopathy-cscr\/#listItem","position":3,"name":"Who Are More Likely to Develop Central Serous Chorioretinopathy (CSCR)?","previousItem":{"@type":"ListItem","@id":"https:\/\/www.retina-eye.co.uk\/zh\/post\/category\/uncategorized\/#listItem","name":"Uncategorized"}}]},{"@type":"Organization","@id":"https:\/\/www.retina-eye.co.uk\/zh\/#organization","name":"Retina Eye","description":"Ms Sharon (Ling Zhi) Heng MBBS, PhD, FRCOphth, FHEA Consultant Ophthalmic Surgeon","url":"https:\/\/www.retina-eye.co.uk\/zh\/","logo":{"@type":"ImageObject","url":"https:\/\/www.retina-eye.co.uk\/wp-content\/uploads\/2026\/07\/Retina-Eye-Uk-Logo-final.png","@id":"https:\/\/www.retina-eye.co.uk\/zh\/post\/who-are-more-likely-to-develop-central-serous-chorioretinopathy-cscr\/#organizationLogo","width":498,"height":355},"image":{"@id":"https:\/\/www.retina-eye.co.uk\/zh\/post\/who-are-more-likely-to-develop-central-serous-chorioretinopathy-cscr\/#organizationLogo"}},{"@type":"Person","@id":"https:\/\/www.retina-eye.co.uk\/zh\/post\/author\/retinaeye\/#author","url":"https:\/\/www.retina-eye.co.uk\/zh\/post\/author\/retinaeye\/","name":"admin","image":{"@type":"ImageObject","@id":"https:\/\/www.retina-eye.co.uk\/zh\/post\/who-are-more-likely-to-develop-central-serous-chorioretinopathy-cscr\/#authorImage","url":"https:\/\/www.retina-eye.co.uk\/wp-content\/litespeed\/avatar\/4670ef77034ec9acb289c5943cd6a2f6.jpg?ver=1785601329","width":96,"height":96,"caption":"admin"}},{"@type":"WebPage","@id":"https:\/\/www.retina-eye.co.uk\/zh\/post\/who-are-more-likely-to-develop-central-serous-chorioretinopathy-cscr\/#webpage","url":"https:\/\/www.retina-eye.co.uk\/zh\/post\/who-are-more-likely-to-develop-central-serous-chorioretinopathy-cscr\/","name":"Who Is at Higher Risk for Central Serous Chorioretinopathy","description":"CSCR mainly affects men aged 30\u201350. Stress, steroid use, hypertension, and Type A traits increase risk. Early detection helps protect central vision.","inLanguage":"zh-CN","isPartOf":{"@id":"https:\/\/www.retina-eye.co.uk\/zh\/#website"},"breadcrumb":{"@id":"https:\/\/www.retina-eye.co.uk\/zh\/post\/who-are-more-likely-to-develop-central-serous-chorioretinopathy-cscr\/#breadcrumblist"},"author":{"@id":"https:\/\/www.retina-eye.co.uk\/zh\/post\/author\/retinaeye\/#author"},"creator":{"@id":"https:\/\/www.retina-eye.co.uk\/zh\/post\/author\/retinaeye\/#author"},"image":{"@type":"ImageObject","url":"https:\/\/www.retina-eye.co.uk\/wp-content\/uploads\/2025\/12\/Who-Are-More-Likely-to-Develop-Central-Serous-Chorioretinopathy-CSCR.jpg","@id":"https:\/\/www.retina-eye.co.uk\/zh\/post\/who-are-more-likely-to-develop-central-serous-chorioretinopathy-cscr\/#mainImage","width":1000,"height":667},"primaryImageOfPage":{"@id":"https:\/\/www.retina-eye.co.uk\/zh\/post\/who-are-more-likely-to-develop-central-serous-chorioretinopathy-cscr\/#mainImage"},"datePublished":"2025-12-05T14:32:00+00:00","dateModified":"2026-06-03T12:18:45+00:00"},{"@type":"WebSite","@id":"https:\/\/www.retina-eye.co.uk\/zh\/#website","url":"https:\/\/www.retina-eye.co.uk\/zh\/","name":"Retina Eye","description":"Ms Sharon (Ling Zhi) Heng MBBS, PhD, FRCOphth, FHEA Consultant Ophthalmic Surgeon","inLanguage":"zh-CN","publisher":{"@id":"https:\/\/www.retina-eye.co.uk\/zh\/#organization"}}]},"og:locale":"zh_CN","og:site_name":"Retina Eye - Ms Sharon (Ling Zhi) Heng MBBS, PhD, FRCOphth, FHEA Consultant Ophthalmic Surgeon","og:type":"article","og:title":"Who Is at Higher Risk for Central Serous Chorioretinopathy","og:description":"CSCR mainly affects men aged 30\u201350. Stress, steroid use, hypertension, and Type A traits increase risk. Early detection helps protect central vision.","og:url":"https:\/\/www.retina-eye.co.uk\/zh\/post\/who-are-more-likely-to-develop-central-serous-chorioretinopathy-cscr\/","og:image":"https:\/\/retina-eye.co.uk\/wp-content\/uploads\/2026\/03\/retina-eye-logo.png","og:image:secure_url":"https:\/\/retina-eye.co.uk\/wp-content\/uploads\/2026\/03\/retina-eye-logo.png","article:published_time":"2025-12-05T14:32:00+00:00","article:modified_time":"2026-06-03T12:18:45+00:00","twitter:card":"summary_large_image","twitter:title":"Who Is at Higher Risk for Central Serous Chorioretinopathy","twitter:description":"CSCR mainly affects men aged 30\u201350. Stress, steroid use, hypertension, and Type A traits increase risk. Early detection helps protect central vision.","twitter:image":"https:\/\/retina-eye.co.uk\/wp-content\/uploads\/2026\/03\/retina-eye-logo.png"},"aioseo_meta_data":{"post_id":"1182","title":"Who Is at Higher Risk for Central Serous Chorioretinopathy","description":"CSCR mainly affects men aged 30\u201350. Stress, steroid use, hypertension, and Type A traits increase risk. Early detection helps protect central vision.","keywords":null,"keyphrases":{"focus":{"keyphrase":"","score":0,"analysis":{"keyphraseInTitle":{"score":0,"maxScore":9,"error":1}}},"additional":[]},"primary_term":null,"canonical_url":null,"og_title":null,"og_description":null,"og_object_type":"default","og_image_type":"default","og_image_url":null,"og_image_width":null,"og_image_height":null,"og_image_custom_url":null,"og_image_custom_fields":null,"og_video":"","og_custom_url":null,"og_article_section":null,"og_article_tags":null,"twitter_use_og":false,"twitter_card":"default","twitter_image_type":"default","twitter_image_url":null,"twitter_image_custom_url":null,"twitter_image_custom_fields":null,"twitter_title":null,"twitter_description":null,"schema":{"blockGraphs":[],"customGraphs":[],"default":{"data":{"Article":[],"Course":[],"Dataset":[],"FAQPage":[],"Movie":[],"Person":[],"Product":[],"ProductReview":[],"Car":[],"Recipe":[],"Service":[],"SoftwareApplication":[],"WebPage":[]},"graphName":"BlogPosting","isEnabled":true},"graphs":[]},"schema_type":"default","schema_type_options":null,"pillar_content":false,"robots_default":true,"robots_noindex":false,"robots_noarchive":false,"robots_nosnippet":false,"robots_nofollow":false,"robots_noimageindex":false,"robots_noodp":false,"robots_notranslate":false,"robots_max_snippet":"-1","robots_max_videopreview":"-1","robots_max_imagepreview":"large","priority":null,"frequency":"default","local_seo":null,"breadcrumb_settings":null,"limit_modified_date":false,"ai":{"faqs":[],"keyPoints":[],"schemas":[],"titles":[],"descriptions":[],"socialPosts":{"email":[],"linkedin":[],"twitter":[],"facebook":[],"instagram":[]}},"created":"2026-03-20 10:00:53","updated":"2026-06-03 12:51:16","seo_analyzer_scan_date":null},"aioseo_breadcrumb":"<div class=\"aioseo-breadcrumbs\"><span class=\"aioseo-breadcrumb\">\n\t\t\t<a href=\"https:\/\/www.retina-eye.co.uk\/zh\" title=\"Home\">Home<\/a>\n\t\t<\/span><span class=\"aioseo-breadcrumb-separator\">&raquo;<\/span><span class=\"aioseo-breadcrumb\">\n\t\t\t<a href=\"https:\/\/www.retina-eye.co.uk\/zh\/post\/category\/uncategorized\/\" title=\"Uncategorized\">Uncategorized<\/a>\n\t\t<\/span><span class=\"aioseo-breadcrumb-separator\">&raquo;<\/span><span class=\"aioseo-breadcrumb\">\n\t\t\tWho Are More Likely to Develop Central Serous Chorioretinopathy (CSCR)?\n\t\t<\/span><\/div>","aioseo_breadcrumb_json":[{"label":"Home","link":"https:\/\/www.retina-eye.co.uk\/zh"},{"label":"Uncategorized","link":"https:\/\/www.retina-eye.co.uk\/zh\/post\/category\/uncategorized\/"},{"label":"Who Are More Likely to Develop Central Serous Chorioretinopathy (CSCR)?","link":"https:\/\/www.retina-eye.co.uk\/zh\/post\/who-are-more-likely-to-develop-central-serous-chorioretinopathy-cscr\/"}],"_links":{"self":[{"href":"https:\/\/www.retina-eye.co.uk\/zh\/wp-json\/wp\/v2\/posts\/1182","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.retina-eye.co.uk\/zh\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.retina-eye.co.uk\/zh\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.retina-eye.co.uk\/zh\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.retina-eye.co.uk\/zh\/wp-json\/wp\/v2\/comments?post=1182"}],"version-history":[{"count":1,"href":"https:\/\/www.retina-eye.co.uk\/zh\/wp-json\/wp\/v2\/posts\/1182\/revisions"}],"predecessor-version":[{"id":1184,"href":"https:\/\/www.retina-eye.co.uk\/zh\/wp-json\/wp\/v2\/posts\/1182\/revisions\/1184"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.retina-eye.co.uk\/zh\/wp-json\/wp\/v2\/media\/2314"}],"wp:attachment":[{"href":"https:\/\/www.retina-eye.co.uk\/zh\/wp-json\/wp\/v2\/media?parent=1182"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.retina-eye.co.uk\/zh\/wp-json\/wp\/v2\/categories?post=1182"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.retina-eye.co.uk\/zh\/wp-json\/wp\/v2\/tags?post=1182"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}